CTLA4 and cancer: These data, together with those in Figure 1, suggest that CTLA4 expression is a critical parameter for selective depletion of intratumoral Treg, which prompted us to select CTLA4 expression levels in the cancer tissue as a key factor in predicting cancer responsiveness to anti-CTLA-4 antibodies.